INTRODUCTION: Both smoking and alcohol consumption have been associated with modestly increased risks of colorectal cancer (CRC). Reports have suggested that these associations may differ by tumor molecular subtype, with stronger associations for microsatellite unstable (MSI-H) tumors. METHODS: We used a population-based case-unaffected sibling design including 2,248 sibships (2,253 cases; 4,486 siblings) recruited to the Colon Cancer Family Registry to evaluate the association between smoking, alcohol consumption, and CRC. Associations were assessed using conditional logistic regression, treating sibship as the matching factor. RESULTS: Although there were no statistically significant associations between any smoking variable and CRC overall, smoking did confer an increased risk of certain types of CRC. We observed an association between pack-years of smoking and rectal cancer [odds ratio (OR), 1.85; 95% confidence interval (CI), 1.23-2.79 for >40 pack-years versus nonsmokers; P(trend) = 0.03], and there was an increased risk of MSI-H CRC with increasing duration of smoking (OR, 1.94; 95% CI, 1.09-3.46 for >30 years of smoking versus nonsmokers). Alcohol intake was associated with a modest increase in risk for CRC overall (OR, 1.21; 95% CI, 1.03-1.44 for 12+ drinks per week versus nondrinkers), with more marked increases in risk for MSI-L CRC (OR, 1.85; 95% CI, 1.06-3.24) and rectal cancer (OR, 1.48; 95% CI, 1.08-2.02). CONCLUSIONS: We found associations between cigarette smoking and increased risks of rectal cancer and MSI-H CRC. Alcohol intake was associated with increased risks of rectal cancer and MSI-L CRC. These results highlight the importance of considering tumor phenotype in studies of risk factors for CRC.
INTRODUCTION: Both smoking and alcohol consumption have been associated with modestly increased risks of colorectal cancer (CRC). Reports have suggested that these associations may differ by tumor molecular subtype, with stronger associations for microsatellite unstable (MSI-H) tumors. METHODS: We used a population-based case-unaffected sibling design including 2,248 sibships (2,253 cases; 4,486 siblings) recruited to the Colon Cancer Family Registry to evaluate the association between smoking, alcohol consumption, and CRC. Associations were assessed using conditional logistic regression, treating sibship as the matching factor. RESULTS: Although there were no statistically significant associations between any smoking variable and CRC overall, smoking did confer an increased risk of certain types of CRC. We observed an association between pack-years of smoking and rectal cancer [odds ratio (OR), 1.85; 95% confidence interval (CI), 1.23-2.79 for >40 pack-years versus nonsmokers; P(trend) = 0.03], and there was an increased risk of MSI-H CRC with increasing duration of smoking (OR, 1.94; 95% CI, 1.09-3.46 for >30 years of smoking versus nonsmokers). Alcohol intake was associated with a modest increase in risk for CRC overall (OR, 1.21; 95% CI, 1.03-1.44 for 12+ drinks per week versus nondrinkers), with more marked increases in risk for MSI-L CRC (OR, 1.85; 95% CI, 1.06-3.24) and rectal cancer (OR, 1.48; 95% CI, 1.08-2.02). CONCLUSIONS: We found associations between cigarette smoking and increased risks of rectal cancer and MSI-H CRC. Alcohol intake was associated with increased risks of rectal cancer and MSI-L CRC. These results highlight the importance of considering tumor phenotype in studies of risk factors for CRC.
Authors: Libby M Morimoto; Polly A Newcomb; Cornelia M Ulrich; Roberd M Bostick; Cynthia J Lais; John D Potter Journal: Cancer Epidemiol Biomarkers Prev Date: 2002-10 Impact factor: 4.254
Authors: Brenda Diergaarde; Alina Vrieling; Annemieke A van Kraats; Goos N P van Muijen; Frans J Kok; Ellen Kampman Journal: Carcinogenesis Date: 2003-03 Impact factor: 4.944
Authors: W S Samowitz; K Curtin; K N Ma; D Schaffer; L W Coleman; M Leppert; M L Slattery Journal: Cancer Epidemiol Biomarkers Prev Date: 2001-09 Impact factor: 4.254
Authors: M L Slattery; K Curtin; K Anderson; K N Ma; L Ballard; S Edwards; D Schaffer; J Potter; M Leppert; W S Samowitz Journal: J Natl Cancer Inst Date: 2000-11-15 Impact factor: 13.506
Authors: Joel K Greenson; Joseph D Bonner; Ofer Ben-Yzhak; Hector I Cohen; Ines Miselevich; Murray B Resnick; Philippe Trougouboff; Lynn D Tomsho; Evelyn Kim; Marcelo Low; Ronit Almog; Gad Rennert; Stephen B Gruber Journal: Am J Surg Pathol Date: 2003-05 Impact factor: 6.394
Authors: Brenda Diergaarde; Hanneke Braam; Goos N P van Muijen; Marjolijn J L Ligtenberg; Frans J Kok; Ellen Kampman Journal: Cancer Epidemiol Biomarkers Prev Date: 2003-11 Impact factor: 4.254
Authors: Eunyoung Cho; Stephanie A Smith-Warner; John Ritz; Piet A van den Brandt; Graham A Colditz; Aaron R Folsom; Jo L Freudenheim; Edward Giovannucci; R Alexandra Goldbohm; Saxon Graham; Lars Holmberg; Dong-Hyun Kim; Nea Malila; Anthony B Miller; Pirjo Pietinen; Thomas E Rohan; Thomas A Sellers; Frank E Speizer; Walter C Willett; Alicja Wolk; David J Hunter Journal: Ann Intern Med Date: 2004-04-20 Impact factor: 25.391
Authors: Gwen Murphy; Susan S Devesa; Amanda J Cross; Peter D Inskip; Katherine A McGlynn; Michael B Cook Journal: Int J Cancer Date: 2010-05-25 Impact factor: 7.396
Authors: Liang Wang; Chun-Han Lo; Xiaosheng He; Dong Hang; Molin Wang; Kana Wu; Andrew T Chan; Shuji Ogino; Edward L Giovannucci; Mingyang Song Journal: Gastroenterology Date: 2020-04-01 Impact factor: 22.682
Authors: Andrea N Burnett-Hartman; Michael N Passarelli; Scott V Adams; Melissa P Upton; Lee-Ching Zhu; John D Potter; Polly A Newcomb Journal: Am J Epidemiol Date: 2013-03-03 Impact factor: 4.897
Authors: Jenny N Poynter; Maki Inoue-Choi; Julie A Ross; David R Jacobs; Kimberly Robien Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-02-19 Impact factor: 4.254
Authors: Molin Wang; Donna Spiegelman; Aya Kuchiba; Paul Lochhead; Sehee Kim; Andrew T Chan; Elizabeth M Poole; Rulla Tamimi; Shelley S Tworoger; Edward Giovannucci; Bernard Rosner; Shuji Ogino Journal: Stat Med Date: 2015-12-01 Impact factor: 2.373